Effectiveness of Zinc as an Adjuvant to Standard Therapy Versus Standard Therapy Alone in Children (5-10 Years) with Moderate Persistent Asthma
This randomized controlled trial conducted in Lahore, Pakistan, demonstrates that adding oral zinc to standard therapy significantly improves asthma control and reduces emergency department visits in children aged 5–10 with moderate persistent asthma compared to standard therapy alone.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Asthma is a condition where the airways inside the lungs become inflamed and narrow, making it difficult to breathe. It often causes wheezing, coughing, and a feeling of tightness in the chest. For children with moderate persistent asthma, the standard medical approach involves using daily controller medications to reduce inflammation and quick-relief inhalers for sudden attacks. While these treatments are effective, doctors and researchers are always looking for ways to make them work even better, especially in regions where environmental pollution and rapid modernization have led to rising rates of the disease. One area of interest is the role of nutrition, specifically a mineral called zinc. Zinc is a nutrient the body needs to fight infection and heal wounds, and it also helps regulate the immune system. Some scientists suspect that low levels of zinc might make asthma worse by allowing inflammation to run unchecked, but it remains unclear whether adding zinc supplements to standard asthma treatment actually helps children breathe easier.
To investigate this question, a team of researchers in Lahore, Pakistan, conducted a clinical trial involving 84 children between the ages of five and ten. All the participants had been diagnosed with moderate persistent asthma and were already receiving standard medical care. The researchers divided the children into two groups using a random lottery method. One group received the standard asthma treatment plus a daily dose of 20 milligrams of elemental zinc, while the other group received only the standard treatment. The study was single-blinded, meaning the participants were assigned by lottery to ensure the results were fair and not influenced by expectations. The children were followed for two months, with check-ups every four weeks to see how well their asthma was controlled. The researchers used a standard questionnaire called the Asthma Control Test to measure symptoms and also tracked how many times each child had to visit the emergency department for a severe asthma attack.
The results of the study showed a clear difference between the two groups. At the first follow-up, after one month of treatment, the children who took zinc alongside their standard medication showed significantly better control over their asthma compared to those who took only the standard medication. Nearly all of the children in the zinc group had improved to a point where their asthma was considered partially controlled, whereas less than half of the children in the standard-only group had reached the same level of improvement. By the second follow-up, at the end of the two-month period, the gap widened. Every single child in the group that received zinc had achieved controlled asthma, meaning their symptoms were well-managed. In contrast, about one-sixth of the children in the standard-only group still had asthma that was only partially controlled or uncontrolled.
The study also looked at how often the children needed emergency care. During the first month, both groups had a similar number of visits to the emergency department for acute asthma attacks. However, in the second month, the pattern changed dramatically. None of the children in the group taking zinc needed to go to the emergency room, while nearly 12 percent of the children in the group receiving only standard treatment had to visit the hospital for a severe flare-up. The researchers noted that the children in the study were generally healthy aside from their asthma, and no serious side effects or harms were observed in the group taking the zinc supplements. The findings suggest that adding a simple, affordable mineral supplement to the existing treatment plan could provide a meaningful boost in managing asthma symptoms and preventing severe attacks in children. While the study was conducted in a specific local setting, the results point toward a potential, low-risk strategy that could help more children breathe freely.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.